While OrbiMed Asia Partners V, L.P. is a health care-focused fund, the investment is not categorized as a COVID-19 response project because OrbiMed did not specifically design the fund to address COVID-19-related issues. Instead, the fund has a broader and longer-term focus, given its aim of seeking equity investments in established and growing companies across several health care segments in India and the PRC.
The report and recommendation of the President to the Board of Directors (RRP) document describes the terms and conditions of a project for consideration and approval by ADB's Board of Directors.
This document dated June 2022 is provided for the ADB regional project 56043-001.